Namrata Vijayvergia, MD

Namrata (Neena) Vijayvergia, MD
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings
Request an Appointment

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Assistant Chief, Gastrointestinal Medical Oncology

Associate Professor, Department of Hematology/Oncology

Medical Director, Medical Oncology

Specialties

  • Gastrointestinal Medical Oncology

Areas of Expertise

Neuroendocrine Tumors, Appendix Cancer, Liver, Gall Bladder & Bile Duct Cancer, Stomach (Gastric) Cancer, Esophageal Cancer, Pancreatic Cancer, Colorectal Cancer

Research Program

Key Awards

Treatment Philosophy

Coming from a family of 12 doctors, I wanted to be one for as long as I can remember. After graduating from medical school in India, I pursued Internal Medicine training at Temple University Hospital in Philadelphia, where I also served as a chief medical resident. During that time I became interested in oncology and clinical research. I recently completed my fellowship in hematology/oncology at Temple/Fox Chase Cancer Center and have been fortunate enough to stay on as faculty. Early in my training, I realized that I wanted to dedicate my career to help discover new therapies for patients with gastrointestinal cancers, with a particular focus on pancreatic and neuroendocrine malignancies. We have made significant progress but a lot still needs to be done... Expand

Fox Chase is a well-known academic center, but small enough to allow for collaboration between clinicians and researchers, and this is the secret of our success. This results in the newest laboratory discoveries being moved quickly to the clinic. In particular, we have been studying the molecular profile of neuroendocrine tumors to identify new therapeutic targets. I also have an interest in cancer specific outcomes and survivorship research.  I want to focus my career on developing and testing new therapies and exploring bio-markers that can predict response to therapy and prognosis for neuroendocrine and pancreatic cancers, with a goal of improving outcomes for our patients.

Patient care at Fox Chase is cutting edge and state of the art, yet very personal. We take a comprehensive and multi-disciplinary approach in treating patients with gastrointestinal cancers with a team of experts including gastroenterologists, medical oncologists, radiation oncologists, surgical oncologists and pathologists who are dedicated to treating patients with gastrointestinal cancers. Fox Chase is a special place, one in which each patient is treated as a family member and provided excellent care. Collapse

Educational Background

  • Fellow, Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2012-2015
  • Resident, Temple University Hospital, Philadelphia, PA, 2008-2011
  • Bachelor of Medicine and Bachelor of Surgery (MBBS), Jawaharlal Nehru Medical College, University of Rajasthan, Ajmer, India, 2007

Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Hematology
  • American Board of Internal Medicine - Medical Oncology

Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology
  • North American Neuroendocrine Tumor Society
  • American Medical Association
  • Indian Medical Association

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2024
  • Top Physicians Under 40 2020, Pennsylvania Medical Society
Link to /sites/default/files/styles/patient_story/public/images/patient-stories/Melvin.jpg?h=8e052630&itok=pTIEHxg8

Melvin Ward

  • Neuroendocrine Tumors

My care team at Fox Chase had such a confident and laid-back demeanor. We were on the same page, and their expertise made me feel more secure.

VIEW PATIENT STORY
Link to /sites/default/files/styles/patient_story/public/images/patient-stories/Ardelle%20tulips%202_0.jpg?h=a2f616d4&itok=2vsOLHqW

Ardelle Clarke

  • Neuroendocrine Tumors

I plan on having a very, very long life. I’m 66 years old and I run a daycare in Havertown, Pennsylvania. Until I was diagnosed, I had no symptoms to speak of and had lived a healthy lifestyle. That’s why when doctors told me I had carcinoid tumors, I had trouble believing I was really sick.

VIEW PATIENT STORY

Research Interests

Neuroendocrine Tumors

Pancreatic Cancer

Outcomes Research

Selected Publications

Vijayvergia, N., Denlinger, C., Survivorship in Non-Small Cell Lung Cancer:Challenges Faced and Steps Forward. Manuscript submitted to JNCCN. 2015  PubMed

Vijayvergia, N., Dotan, E., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. Manuscript submitted to Cancer. 2015  PubMed

Matthews, E., Zhou, L., Vijayvergia, N., El-Deiry, W., A Multiplexed Marker-based Algorithm for Diagnosis of Carcinoma of Unknown Primary Using Circulating Tumor Cells, Poster accepted for presentation at AACR 2015. 2014 

Vijayvergia, N., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. J Clin Oncol 33, 2015 (suppl 3; abstr 253). 2014

Vijayvergia, N., Engstrom, P.F., Molecular profiling of advanced stage Neuro Endocrine Tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. Poster presented at NANETS annual symposium 2014 and GI ASCO Symposium 2015 (JClin Oncol 33, 2015 (suppl 3; abstr 245)

Vijayvergia N, Mehra R. Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2014 Sep;74(3):437-46

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...